Production (Stage)
NuCana plc
NCNA
$0.0499
$0.010426.33%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
6/2/2025
-
GuruFocus
6/2/2025
-
TipRanks Financial Blog
6/2/2025
-
GuruFocus
6/2/2025
-
Globe Newswire
5/6/2025
-
GuruFocus
5/6/2025
-
GuruFocus
5/6/2025
-
GuruFocus
5/6/2025
-
The Fly
5/6/2025
-
Globe Newswire
5/5/2025
-
GuruFocus
4/25/2025
-
Zacks Investment Research
4/24/2025
-
The Fly
4/9/2025
-
Zacks Investment Research
3/30/2025
-
Ticker Report
3/26/2025
-
Ticker Report
3/20/2025
-
GuruFocus
3/20/2025
-
The Fly
3/20/2025
-
Globe Newswire
3/18/2025
-
TipRanks Financial Blog
12/15/2024
-
Ticker Report
11/25/2024
-
SeekingAlpha.com: All News
11/25/2024
-
The Fly
11/25/2024
-
GuruFocus
11/25/2024
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 20, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
44 13 1357 1111
Address
3 Lochside Way
Edinburgh, EH12 9DT
Edinburgh, EH12 9DT
Country
Year Founded
Business Description
Sector
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed...
more